← back to search

Judy Zhong

NYU Langone Health · US
Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Cutaneous Melanoma Detection and Management, Immunotherapy and Immune Responses, and CAR-T cell therapy research.
h-index
43
citations
6,916
works
263
NIH funding
primary concept
Medicine
email

Recent publications

Generative Large Language Models Trained for Detecting Errors in Radiology Reports
Radiology 2025cited by 13position: middledoi
Tonic type I interferon signaling optimizes the antiviral function of plasmacytoid dendritic cells.
2025cited by 2position: contributordoi
Posterior Approach to Endopelvic Neurovascular Total Sparing Robotic-Assisted Radical Prostatectomy Improves Recovery of Erectile Function
JU Open Plus 2025cited by 2position: contributordoi
Using the EPIS Framework to Implement a Physical Activity Promotion Intervention at a Large Academic Healthcare System.
2025cited by 1position: contributordoi
COVID-19 Vaccination Around ICI Initiation and Survival in Lung, Kidney, and Melanoma
2025cited by 0position: contributordoi
Model-based estimation of individual-level social determinants of health and its applications in All of Us.
2024cited by 2position: contributordoi
Bias correction models for electronic health records data in the presence of non-random sampling.
2024cited by 0position: contributordoi
Single‐cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile
The Prostate 2023cited by 15position: middledoi
Psychosocial Factors of Women Presenting With Myocardial Infarction With or Without Obstructive Coronary Arteries
Journal of the American College of Cardiology 2023cited by 14position: middledoi
A joint fairness model with applications to risk predictions for underrepresented populations.
2023cited by 8position: contributordoi
Role of Resilience in the Psychological Recovery of Women With Acute Myocardial Infarction.
2023cited by 8position: contributordoi
Adapting the Diabetes Prevention Program for Older Adults: Descriptive Study.
2023cited by 3position: contributordoi
Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade
Clinical Cancer Research 2022cited by 39position: middledoi
Factors associated with hospital admission and severe outcomes for older patients with <scp>COVID</scp> ‐19
Journal of the American Geriatrics Society 2022cited by 24position: lastdoi
Factors associated with hospital admission and severe outcomes for older patients with COVID-19.
2022cited by 13position: contributordoi
A Pilot Randomized Controlled Trial of Integrated Palliative Care and Nephrology Care.
2022cited by 10position: contributordoi
Adapting the Diabetes Prevention Program for Older Adults: Descriptive Study (Preprint)
2022cited by 0position: contributordoi
Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women.
2021cited by 227position: contributordoi
Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma.
2021cited by 135position: contributordoi
The ongoing racial disparities in melanoma: An analysis of the Surveillance, Epidemiology, and End Results database (1975-2016).
2021cited by 86position: contributordoi
Personalized Multimorbidity Management for Patients with Type 2 Diabetes Using Reinforcement Learning of Electronic Health Records
Drugs 2021cited by 55position: lastdoi
Preexisting immune‐mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitors
Cancer Medicine 2021cited by 25position: lastdoi
Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients
Journal of Translational Medicine 2021cited by 24position: middledoi
Personalized Multimorbidity Management for Patients with Type 2 Diabetes Using Reinforcement Learning of Electronic Health Records.
2021cited by 23position: contributordoi
Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients.
2021cited by 20position: contributordoi
Preexisting immune-mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitors.
2021cited by 20position: contributordoi
Optimization of an automated tumor-infiltrating lymphocyte algorithm for improved prognostication in primary melanoma.
2021cited by 20position: contributordoi
Environmental Noise in New York City Long-Term Care Facilities: A Window Into the COVID-19 Pandemic.
2021cited by 1position: contributordoi
Correction to: Personalized Multimorbidity Management for Patients with Type 2 Diabetes Using Reinforcement Learning of Electronic Health Records.
2021cited by 0position: contributordoi
A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee
Journal of Thoracic Oncology 2020cited by 532position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Iman Osman · NYU Langone Health23 papers (2013–2022) · 15 papers (2020–2025)Jeffrey S. Weber · Heinrich Heine University Düsseldorf11 papers (2018–2022)Richard L. Shapiro · New York University8 papers (2014–2020)Paul Johannet · New York University8 papers (2020–2022)Anna C. Pavlick · Cornell University8 papers (2013–2020)Judith S. Hochman · Job Performance Systems (United States)7 papers (2017–2023)Yuhe Xia · NYU Langone Health7 papers (2019–2023)Eva Hernando · NYU Langone Health6 papers (2013–2021)Douglas M. Donnelly · New York University6 papers (2019–2021)Russell S. Berman · New York University6 papers (2014–2020)Farbod Darvishian · New York University6 papers (2015–2020)Russell S. Berman · Weill Cornell Medicine5 papers (2019–2021)Nathaniel R. Smilowitz · NYU Langone Health5 papers (2018–2023)Sung Won Han · University of Seoul5 papers (2014–2016)Michelle Krogsgaard · New York University5 papers (2016–2022)Binita Shah · Insmed (United States)5 papers (2018–2023)Una Moran · New York University5 papers (2018–2020)Yu Guo · New York University4 papers (2015–2018) · 4 papers (2021–2023)